Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Current and Future Therapies for Multiple Sclerosis.
The incidence and prevalence of neuromyelitis optica: a systematic review.
A comparison of linear and nonlinear stability parameters in different clinical forms of multiple sclerosis.
Isoniazid in autoimmunity: a trigger for multiple sclerosis?
Highlights From the 2014 Joint Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)-European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS).
Cannabidiol, a non-psychoactive cannabinoid, leads to EGR2-dependent anergy in activated encephalitogenic T cells.
Comprehensive Review of Ocular Angiostrongyliasis with Special Reference to Optic Neuritis.
Exergaming with additional postural demands improves balance and gait in patients with multiple sclerosis as much as conventional balance training and leads to high adherence to home-based balance training.
Is cervical decompression beneficial in patients with coexistent cervical stenosis and multiple sclerosis?
Apoptosis of Oligodendrocytes during Early Development Delays Myelination and Impairs Subsequent Responses to Demyelination.
Immunohistochemical detection of sphingosine-1-phosphate receptor 1 and 5 in human multiple sclerosis lesions.
A retrospective case series of pediatric spinal cord injury and disease in Victoria, Australia.
Patients with neuromyelitis optica have a more severe disease than patients with relapsingremitting multiple sclerosis, including higher risk of dying of a demyelinating disease.
Trichloropropane and dichlorohydrin associated with painful peripheral neurotoxicity.
Multiparity in women with multiple sclerosis causes less long-term disability: Yes.
Increased Circulating Levels of Vitamin D Binding Protein in MS Patients.
Actively Induced Experimental Autoimmune Encephalomyelitis in Rats.
The PANGAEA study design - a prospective, multicenter, non-interventional, long-term study on fingolimod for the treatment of multiple sclerosis in daily practice.
Structural Brain Network Characteristics Can Differentiate CIS from Early RRMS.
[Locomotive syndrome and Frailty. Vitamin D and Frailty].
MULTIPLE SCLEROSIS IN CHILDHOOD.
Cerebrospinal fluid neurofilament light chain levels predict visual outcome after optic neuritis.
Use of altered informed consent in pragmatic clinical research.
Resistant Strains of Enterotoxigenic Staphylococcus aureus; Unknown Risk for Multiple Sclerosis Exacerbation.
The multiple faces of RAGE - opportunities for therapeutic intervention in aging and chronic disease.
Pages
« first
‹ previous
…
649
650
651
652
653
654
655
656
657
…
next ›
last »